Latest Period
Q1 2026
Security Snapshot
Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) Institutional Ownership
CUSIP: 17322U306
13F Institutional Holders and Ownership History from Q4 2024 to Q1 2026
Institutions Reporting
38
Shares (Excl. Options)
996,920
Price
$0.90
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- CTXR on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 996,920
- Total 13F value
- $896,918
- Portfolio coverage rank
- 0%
- Share change
- -771,663
- Value change
- -$590,198
- Number of holders
- 38
- Shares outstanding
- 24,189,141
- SEC-reported price per share
- $0.65
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CTXR - Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 17322U306.
- 38 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 39 to 38 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $1,336,933 to $896,918.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 38 institutions filings for Q1 2026.
Security key
17322U306
Latest holder period
Q1 2026
13F holders
38
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
CTXR full holder history
Citius Pharmaceuticals, Inc. SEC filings
Citius Pharmaceuticals, Inc. company facts
Citius Pharmaceuticals, Inc. insider transactions
Citius Pharmaceuticals, Inc. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 17322U306:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
CTXR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 0% | $2,059,464 | +$635,578 | 2,394,725 | +45% | CVI Investments, Inc. | 31 Dec 2025 |
As of 31 Mar 2026, 38 institutional investors reported holding 996,920 shares of Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR). This represents 4.1% of the company’s total 24,189,141 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
Q1 2026
Rows shown
1-6 of 6
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 996,920 | $896,918 | -$590,198 | $0.90 | 38 |
| 2025 Q4 | 1,720,560 | $1,336,933 | +$797,534 | $0.78 | 39 |
| 2025 Q3 | 624,408 | $773,221 | -$686,712 | $1.24 | 34 |
| 2025 Q2 | 928,766 | $1,477,067 | +$473,599 | $1.59 | 31 |
| 2025 Q1 | 635,473 | $947,155 | -$78,728 | $1.49 | 27 |
| 2024 Q4 | 606,234 | $2,424,129 | +$2,412,517 | $4.00 | 29 |